Deal facts
- Buyer
- AMPLIFON
- Target
- GN HEARING
- Deal value
- Not disclosed
- Announced
- 30 September 2026
- Status
- In review
- Sector
- Healthcare
- Country
- Not stated
- Consideration
- Not stated
Sources
AMPLIFON has agreed to acquire GN HEARING in a strategic acquisition within the healthcare sector. The transaction was announced on 30 September 2026. No specific deal value has been disclosed, and the consideration type remains unreported. The countries of origin for both the buyer and the target are not specified in the available data. This move represents a significant consolidation effort in the hearing aid and related healthcare services market. The acquisition is currently under review, with no completion date yet established. Regulatory approvals and other standard closing conditions are expected to be required before the deal can proceed to finalisation. The parties have not provided further details regarding the strategic rationale or the specific terms of the agreement beyond the initial announcement. The status of the transaction remains active as it undergoes the necessary due diligence and approval processes.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CMA invitation to comment
AMPLIFON / GN HEARING
FormalInvestigationPhase1Merger AMPLIFON / GN HEARING
EU DG COMP
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Hepion Pharmaceuticals, Inc. to acquire Gravitas Life Sciences, LLC
Hepion Pharmaceuticals, Inc. has agreed to acquire Gravitas Life Sciences, LLC in a strategic acquisition. The transaction, valued at 4.25 million US dollars, was comple…
- Buyer
- Hepion Pharmaceuticals, Inc.
- Target
- Gravitas Life Sciences, LLC
- Deal value
- USD 4,250,000
- Deal type
- strategic acquisition
BC PARTNERS to acquire ACS DOBFAR
BC PARTNERS has agreed to acquire ACS DOBFAR in a strategic acquisition within the healthcare sector. The transaction was announced on 8 October 2026. No specific financ…
- Buyer
- BC PARTNERS
- Target
- ACS DOBFAR
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
SRX Global Inc. to acquire CERo Therapeutics, Inc.
SRX Global Inc. has agreed to acquire CERo Therapeutics, Inc. in a strategic transaction within the healthcare sector. Both the buyer and the target are based in the Uni…
- Buyer
- SRX Global Inc.
- Target
- CERo Therapeutics, Inc.
- Deal value
- USD 1,000,000
- Deal type
- strategic acquisition
Repligen to acquire BioLife
Repligen has agreed to acquire BioLife in a strategic acquisition completed on 6 October 2026. Both companies are based in the United States and operate within the healt…
- Buyer
- Repligen
- Target
- BioLife
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
AMPLIFON
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive